These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6152810)

  • 1. Hepatic microvascular regulatory mechanisms. IV. Effect of lodoxamide tromethamine and arterenol-HCl on vascular responses evoked by compound 48/80.
    Reilly FD; Dimlich RV
    Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):87-106. PubMed ID: 6152810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic microvascular regulatory mechanisms. V. Effects of lodoxamide tromethamine or phentolamine-HCl on vascular responses elicited by serotonin.
    Reilly FD; Cilento EV; McCuskey RS
    Microcirc Endothelium Lymphatics; 1984 Dec; 1(6):671-89. PubMed ID: 6100792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic microvascular regulatory mechanisms. VI. Effects of lodoxamide tromethamine or phentolamine-HCl on early hemodynamic and glucoregulatory alterations evoked by endotoxin.
    Reilly FD; Dimlich RV
    Microcirc Endothelium Lymphatics; 1985 Jun; 2(3):271-92. PubMed ID: 3836345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic microvascular regulatory mechanisms. IX. Effects of compound 48/80 on endotoxin-induced changes in microcirculation and mast cell integrity.
    Unger LS; Reilly FD
    Microcirc Endothelium Lymphatics; 1986; 3(2):109-28. PubMed ID: 3587176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic microvascular regulatory mechanisms. VII. Effects of endoportally-infused endotoxin on microcirculation and mast cells in rats.
    Unger LS; Reilly FD
    Microcirc Endothelium Lymphatics; 1986; 3(1):47-74. PubMed ID: 3547067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic microvascular regulatory mechanisms. VIII. Glucogenic responses and morphologic changes following serotonin-induced low flow.
    Reilly FD; McCafferty RE; McCuskey PA; Dimlich RV
    Microcirc Endothelium Lymphatics; 1986; 3(1):21-46. PubMed ID: 3821692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated blood glucose after compound 48/80 treatment is not related to hepatic mast cell degranulation in rats.
    Dimlich RV; Reilly FD
    Proc Soc Exp Biol Med; 1986 Dec; 183(3):321-7. PubMed ID: 3797416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of involvement of mast cell degranulation in the antiarrhythmic effect of preconditioning in rats.
    Humphreys RA; Kane KA; Parratt JR
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):418-23. PubMed ID: 9514187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic microvascular regulatory mechanisms. III. Aminergic mechanisms as related to mast cells.
    Reilly FD; Dimlich RV; Cilento EV; McCuskey RS
    Int J Microcirc Clin Exp; 1983; 2(1):61-73. PubMed ID: 6678839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved survival from compound 48/80-induced lethal stress and inhibition of myocardial histamine and carnosine mobilization by lodoxamide.
    Flancbaum L; Fitzpatrick JC; Fisher H
    Circ Shock; 1989 Feb; 27(2):155-64. PubMed ID: 2706750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of oxidative enzymes by anti-allergy drugs.
    White GJ
    Agents Actions; 1981 Nov; 11(5):503-9. PubMed ID: 6121476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of H1 and H2 receptor blockers on mobilization of myocardial carnosine to histamine during compound 48/80-induced shock in young rats.
    Fitzpatrick JC; Fisher H; Flancbaum L
    Circ Shock; 1990 Feb; 30(2):145-53. PubMed ID: 1968787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lodoxamide tromethamine prevents neutrophil accumulation in reexpansion pulmonary edema.
    Veal CF; Jackson RM; Brannen AL; Fulmer JD
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):227-32. PubMed ID: 2476595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma.
    Johnson HG; Sheridan AQ
    Agents Actions; 1986 Jun; 18(3-4):301-5. PubMed ID: 2875630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cell degranulation, hepatic glycogen depletion, and hyperglycemia in Compound 48/80 or pilocarpine-treated rats.
    Dimlich RV; Townsend SF; Reilly FD
    Hepatology; 1982; 2(3):372-8. PubMed ID: 7076121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allopurinol and lodoxamide in complement-induced hepatic ischemia.
    Schirmer WJ; Schirmer JM; Naff GB; Fry DE
    J Surg Res; 1988 Jul; 45(1):28-36. PubMed ID: 3260642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of a mast cell stabilizing compound to organ preservation solutions decreases lung reperfusion injury.
    Barr ML; Carey JN; Nishanian GP; Roberts RF; Sakamaki Y; Darbinian SH; Starnes VA
    J Thorac Cardiovasc Surg; 1998 Mar; 115(3):631-6; discussion 636-7. PubMed ID: 9535451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lodoxamide on the secretory response induced by Escherichia coli and Vibrio cholerae enterotoxins in infant mice.
    Knoop FC; Thomas DD
    Infect Immun; 1984 May; 44(2):406-8. PubMed ID: 6143729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis.
    Grutzmacher RD; Foster RS; Feiler LS
    Am J Ophthalmol; 1995 Sep; 120(3):400-2. PubMed ID: 7661218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.